Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02631044
Title Study Evaluating the Safety and Pharmacokinetics of JCAR017 in B-cell Non-Hodgkin Lymphoma (TRANSCEND-NHL-001)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Juno Therapeutics, a Subsidiary of Celgene
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Local Institution - 0006 Birmingham Alabama 35294 United States Details
Local Institution - 0007 Duarte California 91010-300 United States Details
Local Institution - 0010 San Francisco California 94143-0372 United States Details
Local Institution - 0020 Aurora Colorado 80045 United States Details
Local Institution - 0019 Atlanta Georgia 30342 United States Details
Local Institution - 0003 Chicago Illinois 60611 United States Details
Local Institution - 0005 Boston Massachusetts 02114 United States Details
Local Institution - 0015 Boston Massachusetts 02115 United States Details
Local Institution - 0008 Omaha Nebraska 68198-7680 United States Details
Local Institution - 0001 New York New York 10065 United States Details
Local Institution - 0021 Charlotte North Carolina 28204 United States Details
Local Institution - 0029 Pittsburgh Pennsylvania 15232 United States Details
Local Institution - 0002 Houston Texas 77030 United States Details
Local Institution - 0018 Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field